Thursday, April 01, 2021 11:36:08 AM
UTHR @ 196.30 > United Therapeutics shares are trading higher after the company announced that the FDA approved the launch of its Tyvaso for the treatment of pulmonary hypertension associated with interstitial lung disease.
New York Yankees and Duke Basketball
Recent UTHR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 09:16:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:46:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:34:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:33:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 08:19:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 08:34:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:32:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:31:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 10:18:12 PM
- United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026 • Business Wire • 05/18/2026 08:15:00 PM
- United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026 • Business Wire • 05/17/2026 06:15:00 PM
- United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial • Business Wire • 05/15/2026 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 09:04:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:31:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 09:25:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 09:25:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 09:16:08 PM
- United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference • Business Wire • 05/12/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:37:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:36:44 AM
- United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026 • Business Wire • 05/11/2026 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:30:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 08:04:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:04:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 10:31:29 AM
